Qunbo Lin
P.R. China
Zhujing, 201508, China
Zhujing, 201508, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Transforming growth factor‑β/miR‑143‑3p/cystatin B axis is a therapeutic target in human ovarian cancer.
Journal: International journal of oncology
Published: March 04, 2019
Physical interaction of STAT1 isoforms with TGF-β receptors leads to functional crosstalk between two signaling pathways in epithelial ovarian cancer.
Journal: Journal of experimental & clinical cancer research : CR
Published: March 25, 2018
MALAT1 affects ovarian cancer cell behavior and patient survival.
Journal: Oncology reports
Published: January 09, 2018
Overexpression of collagen type V α1 chain in human breast invasive ductal carcinoma is mediated by TGF-β1.
Journal: International journal of oncology
Published: November 23, 2017
Dual Effects of N,N-dimethylformamide on Cell Proliferation and Apoptosis in Breast Cancer.
Journal: Dose-response : a publication of International Hormesis Society
Published: August 09, 2017
Biological Function of Ribosomal Protein L10 on Cell Behavior in Human Epithelial Ovarian Cancer.
Journal: Journal of Cancer
Published: June 25, 2017
Pyridoxine 5'-phosphate oxidase is a novel therapeutic target and regulated by the TGF-β signalling pathway in epithelial ovarian cancer.
Journal: Cell death & disease
Published: June 07, 2017
Cytidine monophosphate kinase is inhibited by the TGF-β signalling pathway through the upregulation of miR-130b-3p in human epithelial ovarian cancer.
Journal: Cellular signalling
Published: December 26, 2016
Showing 1-10 of 10
Last Updated: 09/26/2026